Concordance of DNA methylation pattern in plasma and tumor DNA of Egyptian hepatocellular carcinoma patients

Experimental and Molecular Pathology

Volumn 88, Issue 1, 2010, Pages 107-111

  Iyer, Priyanka ^a   Zekri, Abdel Rahman ^b   Hung, Chu Wei ^a   Schiefelbein, Emily ^a   Ismail, Kadry ^c   Hablas, Ahmed ^c   Seifeldin, Ibrahim A ^c   Soliman, Amr S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL CANCER INSTITUTE   (Egypt)

^c Gharbiah Cancer Registry   (Egypt)

Author keywords

Egypt; HCC; Liver; Meththylation; Plasma; Tumor tissue

Indexed keywords

APC PROTEIN; DNA; FRAGILE HISTIDINE TRIAD PROTEIN; PROTEIN P15; PROTEIN P16; UVOMORULIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; EGYPT; FEMALE; GENETIC RISK; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; RELIABILITY; RISK FACTOR; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DNA METHYLATION; DNA, NEOPLASM; EGYPT; FEMALE; GENE SILENCING; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 74749099086     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2009.09.012     Document Type: Article

References (21)

1. Alacacioglu A., Somali I., Simsek I., Astarcioglu I., Ozkan M., Camci C., et al. Epidemiology and survival of hepatocellular carcinoma in turkey: outcome of multicenter study. Jpn. J. Clin. Oncol. 38 10 (2008) 683
2. Ambinder R.F., Robertson K.D., and Tao Q. DNA methylation and the Epstein-Barr virus. Semin. Cancer Biol. 9 5 (1999) 369
3. Bongiovanni M., and Casana M. Non-invasive markers of liver fibrosis in HCV mono-infected and in HIV/HCV co-infected subjects. Med. Chem. 4 6 (2008) 513
4. Chang H., Yi B., Li L., Zhang H., Sun F., Dong S., et al. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients. Exp. Mol. Pathol. 85 2 (2008) 96
5. Doerfler W. Epigenetic mechanisms in human adenovirus type 12 oncogenesis. Semin. Cancer Biol. 19 3 (2009) 136-143
6. Edamoto Y., Hara A., Biernat W., Terracciano L., Cathomas G., Riehle H., et al. Alterations of RB1, p53 and wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int. J. Cancer 106 3 (2003) 334
7. El-Serag H.B., and Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 132 7 (2007) 2557
8. In: Freedman L., Edwards B., Ries L., and Young J. (Eds). Cancer incidence in four member countries (cyprus, egypt, israel, and jordan) of the middle east cancer consortium (MECC) compared with US SEER. National Cancer Institute (2006)
9. In: Ibrahim A.S., Ismail K., Hussein H., Seif-Eldein I.A., Hablas A., Elhamzawy H., et al. (Eds). Cancer in egypt, gharbiah (1st ed.). Egypt: Gharbiah Population-based Cancer Registry (2007)
10. Jicai Z., Zongtao Y., Zongtao Y., Jun L., Jun L., Haiping L., et al. Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma. Mol. Carcinog. 45 7 (2006) 530
11. Lau W., and Lai E.C.H. Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreatic Diseases International 7 3 (2008) 237
12. Lehman E.M., and Wilson M.L. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int. J. Cancer 124 3 (2009) 690
13. Liu J., Lian Z., Han S., Waye M.M.Y., Wang H., Wu M., et al. Downregulation of E-cadherin by hepatitis B virus X antigen in hepatocellullar carcinoma. Oncogene 25 7 (2006) 1008
14. Martens J.W., Margossian A.L., et al. DNA methylation as a biomarker in breast cancer. Future Oncol. 5 8 (2009) 1245-1256
15. Mikovits J.A., Young H.A., Vertino P., Issa J.P., Pitha P.M., Turcoski-Corrales S., et al. Infection with human immunodeficiency virus type 1 upregulates DNA methyltransferase, resulting in de novo methylation of the gamma interferon (IFN-gamma) promoter and subsequent downregulation of IFN-gamma production. Mol. Cell. Biol. 18 9 (1998) 5166
16. Papadopoulou E., Davilas E., Sotiriou V., Georgakopoulos E., Georgakopoulou S., Koliopanos A., et al. Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer. Ann. N.Y. Acad. Sci. 1075 1 (2006) 235
17. Sakamoto M., Mori T., Masugi Y., Effendi K., Rie I., and Du W. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma. Intervirology 51 1 (2008) 42 Suppl 1
18. Teodoridis J.M., Hardie C., and Brown R. CpG island methylator phenotype (CIMP) in cancer: causes and implications. Cancer Lett. 268 2 (2008) 177
19. Wong I.H., Lo Y.M., Yeo W., Lau W.Y., and Johnson P.J. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Clin Cancer Res. 6 9 (2000) 3516
20. Zhang C., Li H., Zhou G., Zhang Q., Zhang T., Li J., et al. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells. J. Pathol. 212 2 (2007) 134
21. Zhou X., Popescu N.C., Klein G., and Imreh S. The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. Cancer Genet. Cytogenet. 177 1 (2007) 6